BIO PEPTIDE Semaglutide ( Ozempic )
Presentación: 3mg/vial
Referencia del proveedor: Semaglutide
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist featuring a 94% amino acid sequence homology to natural human GLP-1. Structurally modified with a fatty acid chain that enables strong reversible binding to albumin, it boasts an extended plasma half-life of approximately 156 hours, permitting once-weekly subcutaneous administration. Beyond its foundational role in glycemic control for type 2 diabetes by stimulating glucose-dependent insulin secretion and suppressing glucagon output, semaglutide offers extensive metabolic and systemic benefits. These include robust appetite suppression and enhanced satiety via hypothalamic pathways, significant reductions in total body weight and fat mass, and delayed gastric emptying that blunts postprandial glucose spikes. Furthermore, clinical trials and preclinical studies highlight its cardiovascular protective effects—such as lowering major adverse cardiac events—alongside emerging evidence pointing to potential anti-inflammatory properties, improvements in hepatic lipid metabolism, and neuroprotective mechanisms.



